Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO

Size: px
Start display at page:

Download "Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO"

Transcription

1 Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO

2 Objectives What is Depression? Discuss the epidemiology of depression Discuss the etiology of depression Discuss the pathophysiology of depression Discuss the signs and symptoms of depression Discuss treatments of depression How to de-prescribe depression

3 Spectrum of Psychiatric Disorders ANXIETY Panic disorder GAD OCD Agoraphobia AFFECTIVE Major Depression Bipolar Disorder Dysthymia PSYCHOSES Schizophrenia Schizoaffective Ripley, VC. Pharmacotherapy of Depression and Anxiety.

4 What is Depression? Described as feeling Blue Unhappy Miserable Everyone feels this way at one time in their life Goes away Clinical depression Feelings interfere with everyday life Last weeks or potentially longer Januzzi et al. Archives of Internal Med 2000;160(13):

5 Epidemiology The true prevalence in the US is unknown Women have higher risk Lifetime risk x higher than men Incidence can happen at any age Highest in adults aged 18-29y.o. Higher incidence in patients with first degree relative 8-18% compared to 5.6% of those without 1.5-3x greater chance of developing depression Kessler, RC, Berglund, P, et al. The Epidemiology of Major Depressive Disorder. JAMA. 2003;289(23): doi: /jama

6 Epidemiology Depression is the most common mental health problem in the elderly and is associated with a significant burden of illness that affects patients, their families, and communities and takes an economic toll as well. Prevalence studies suggest that 14% to 20% of the elderly living in the community experience depressive symptoms, with higher rates among the elderly in hospital (12% to 45%) and even higher rates in long-term care facilities (an estimated 40%).

7 Comorbidity and Depression 72.1% of those with lifetime MDD and 64% of those with 12-month MDD have at least one additional mood disorder Primarily anxiety disorder, substance abuse disorder, or impulse control disorder Kessler RC et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):

8 Etiology Too complex to be explained by a single social, development, or biological theory Several factors work together Reflects changes in brain transmitters Norepinephrine (NE), Serotonin (5-HT), Dopamine (DA) Belmaker, R. H., and Galila Agam. "Major depressive disorder." New England Journal of Medicine (2008):

9

10 Neurotransmitters and Psychiatric Pharmacotherapy Anxiolytics Norepinephrine Anti- Depressants Serotonin Anti- Psychotics Dopamine GABA (gamma-aminobutyric acid), others

11 Major Neurotransmitters Norepinephrine Energy Interest Motivation Anxiety Irritability Mood, Emotion, Cognitive function Sex Appetite Aggressi on Impulsivity Serotonin Drive Dopamine

12 Pathophysiology of Depression Exact cause unknown Believed to be chemical imbalance in the brain Genetic Triggered by stressful events Breakups Failing a class Death or illness to someone close to you Divorce Child abuse or neglect Job loss Social isolation Play a role Alcohol or drug abuse Medical conditions: Hypothyroid, cancer, chronic pain Medications Sleeping problems

13 Certain medications used alone or in combination can cause side effects much like the symptoms of depression. Use of Alcohol or other Drugs can lead to or worsen depression. Depression can also occur for no apparent reason at all! Ressler, Kerry J., and Charles B. Nemeroff. "Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders." Depression and anxiety 12.S1 (2000): 2-19.

14 DSM V Classification of Major Depressive Episode Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Note: Do not include symptoms that are clearly due to a general medical condition or mood-incongruent delusions or hallucinations. Depressed mood most of the day nearly every day Markedly diminished interest or pleasure in all, or almost all, activities most of the day nearly every day Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a month), or decrease or increase in appetite nearly every day Insomnia or hypersomnia nearly every day Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings of restlessness or being slowed down) Fatigue or loss of energy nearly every day Feelings of worthlessness or excessive or inappropriate guilt nearly every day Diminished ability to think or concentrate, or indecisiveness, nearly every day Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide

15 Signs and Symptoms of Depression The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism). The symptoms are not better accounted for by bereavement (i.e., after the loss of a loved one), the symptoms persist for longer than 2 months or are characterized by marked functional impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation. Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (Copyright 2013). American Psychiatric Association. All Rights Reserved..

16 Signs and Symptoms of Depression Complete physical, mental, and lab examination must be completed Can be caused by current medical condition or drug induced See list of proposed medical conditions, substance use, and medications

17

18 Physical Complaints These may include: Sleep disturbances such as insomnia, early morning waking, or sleeping too much Lack of energy Loss of appetite Weight loss or gain Unexplained headaches or backaches Stomachaches, indigestion or changes in bowl habits

19 Symptoms of Depression Vary from person to person 2 key signs are loss of interest in things you like to do, and pervasive sadness or irritability

20 SIGECAPS S I G E C A P S - Changes in sleep pattern - Changes in interests or activity - Feelings of guilt or increased worry - Changes in energy - Changes in concentration - Changes in appetite - Psychomotor disturbances -Suicidal ideation

21 Treatment 3 phases to treatment Acute phase: 6-10 weeks to obtain remission Continuation phase: 4-9 months after remission Prevent relapse Maintenance phase: months Prevent recurrence Duration of treatment Depends on risk of recurrence Some recommend lifetime maintenance therapy for persons at greatest risk of recurrence

22 Treatment Non-pharmacologic Psychotherapy Not recommended as sole therapy for acute episodes of severe or psychotic depression If mild to moderate, first line therapy Can be added to pharmacologic treatment for patients with partial responses

23 Treatment Non-pharmacologic Electroconvulsive therapy (ECT) Used when rapid response is required Risks of other treatments outweigh benefits History of poor response to antidepressants and good response to ECT Patient preference Unilateral or bilateral administered 2-3 times weekly for 6-12 treatments Adverse effects include cognitive dysfunction, cardiovascular dysfunction, prolonged apnea, treatment-emergent mania, headache, nausea, and muscle aches Relapse rates are high in patients not taking maintenance antidepressants

24 Treatment Pharmacologic Can take 4-6 weeks of therapy to see response Many different categories TCAs SSRI SNRI Triazolopyridines Aminoketones Tetracyclics MAOIs

25 Steps for Choosing an Effective Antidepressant 1. Recognize that some antidepressants may be more effective in certain populations even though most are generally of equal effectiveness. 2. Ask about personal or family history of treatment with antidepressants, particularly about side effects. 3. Consider the burden of side effects, particularly weight gain and sexual side effects in midlife women. 4. Consider drug-drug interactions with other medications the patient is taking or may take. 5. Consider the potential lethality of the antidepressant in the case of an overdose. 6. Use antidepressant side effects for efficacy. Moore DP, Jefferson JW. Mood Disorders. In: Moore & Jefferson: Handbook of Medical Psychiatry, 2nd ed. Philadelphia: M b 2004

26 Algorithm for Treatment of Uncomplicated Major Depression 1st line: Favorite SSRI or TCA Failed trial: switch to alternative Partial response - increase dose, switch or augment Fully remits (maintain at least 4 to 6 months or longer) 2nd line: Switch or Augment Switch to other favorite - TCA or SSRI Augment with Li or TCA plus the SSRI (consult with psychiatrist) 3rd line: Failed or Partial response to 2nd line Consult with psychiatrist Switch (nefazodone, mirtazapine, bupropion, venlafaxine) Add newer agent (vortioxetine, aripiprazole) Augment with Li or TCA plus the SSRI Adapted from Wells B et al: in Pharmacotherapy, 10th ed, Dipiro, eds., 2016

27 Mechanism of Action SSRIs Inhibits reuptake of 5-HT into the pre-synaptic neuron SNRIs (Venlafaxine, Desvenlafaxine, Duloxetine) Inhibits re-uptake of 5-HT and NE into the pre-synaptic neuron Aminoketones (Bupropion) Inhibits re-uptake of NE and DA into the pre-synaptic neuron Triazolopyridines (Trazodone) Not fully understood Thought to inhibit re-uptake of 5-HT and antagonist of 5-HT 2A/2C receptors Tetracyclics (Mirtazapine) Exact mechanism unknown Thought to work through 5-HT receptor antagonism

28 Mechanism of Action Tricyclic Antidepressants Inhibits both 5-HT and NE reuptake Antagonist at both receptors Monoamine Oxidase Inhibitors Work on monoamine oxidase by inhibiting them from breaking down neurotransmitters

29 Mechanism of Action Aripiprazole, Brexpiprazole (Abilify, Rexulti) Acts as a D 2 partial agonist Partial agonist at the 5-HT 1A receptor, and like the other atypical antipsychotics displays an antagonist profile at the 5-HT 2A receptor Vortioxetine (Trintellix) Atypical antidepressant (a serotonin modulator and stimulator)

30 Treatments

31

32 Adverse Events Celexa Gi distress, N/V, headache, sedation, dizziness, agitation, Stevens-Johnson Syndrome (SJS) Sertraline Gi distress, N/V, headache, insomnia, dizziness, agitation, SJS Duloxetine Constipation, nausea, headache, dizziness, insomnia, decreased appetite, SJS Buproprion Tachyarrhythmia, nausea, constipation, dizziness, headache, insomnia, agitation, anxiety Trazodone Diarrhea, nausea, dizziness, headache, insomnia, nervousness Mirtazapine Increased appetite, constipation, dizziness Amitriptyline Weight gain, constipation, blurred vision

33 Follow-Up Considerations In The First Three Months Week 2 4 Treatment Actions Check patient compliance to medication usage. Assess for adherence, side effects, suicidal ideation, and patient response. Adjust, as appropriate, medication and dosage. Re-check patient compliance to medication usage. Assess for adherence, side effects, suicidal ideation, and patient response. 6 Adjust, as appropriate, medication and dosage Monthly communication with patient; Patients Appointments every 3rd or 4th week; Further Medication or Medication Dosage Adjustments; Goal: Remission

34 Treatment Goal The goal of treatment with antidepressant medication in the acute phase is the remission of major depressive disorder symptoms APA Practice Guidelines for the Treatment of Psychiatric Disorders.

35 If Initial Treatment Ineffective Medication trial should last 8-12 weeks If no side effects or tolerability issues, increase dosage every 2-3 weeks until Remission achieved Max dose achieved Side effects limit titration Combine antidepressants and psychotherapy Combine antidepressants or consider augmentation trial Considering tailoring your treatment for specific sub-populations (e.g., elderly, midlife women etc). Texas Medication Algorithm Project (TMAP) Treatment of Major Depressive Disorder Clinician s Manualhttp:// Kaiser Permanente Care Management Institute. Depression clinical practice guidelines.

36 De-prescribing Antidepressants Old thinking: 50% of patients with Major Depression will experience recurrence Admission into a nursing home or other long-term care facility can be a trigger for depression New thinking: 50% of patients with Major Depression will NOT experience recurrence Like the loss of a loved one or other traumatic event, admission into a long-term care facility can be overcome Patients of all ages who are started on antidepressant therapy should be monitored closely for emergence and worsening of suicidal thoughts and behaviors

37 De-prescribing Antidepressants Questions to ask: Is the resident benefiting from the antidepressant therapy? What are the benefits to stopping therapy and what are the risks of stopping therapy? Is this the best course of action for MY patient?

38 De-prescribing Antidepressants If used for longer than six weeks, all antidepressants have the potential to cause withdrawal syndromes if they are stopped or rapidly reduced. How to reduce the dose: The usual recommended period for antidepressant dose reduction is a minimum of four weeks. Monitor for withdrawal symptoms. Use half-life of the medication to determine taper plan. If switching to another antidepressant consider a wash-out period equivalent to a minimum of 5 halflives of the drug being stopped.

39 Conclusion Depression one of the most common mental health disorders in adults Pharmacologic intervention is the cornerstone for treatment Antidepressants focus on inhibiting the uptake of 5-HT, NE, and DA neurotransmitters

40 QUESTIONS

41 References Teter C.J., Kando J.C., Wells B.G. (2011). Chapter 77. Major Depressive Disorder. In J.T. DiPiro, R.L. Talbert, G.C. Yee, G.R. Matzke, B.G. Wells, L.M. Posey (Eds), Pharmacotherapy: A Pathophysiologic Approach, 8e. Retrieved February 23, 2012 from aid= All drug info from Micromedex and Lexicomp handheld information Table 77-2 DSM-IV-TR Criteria for Major Depressive Episode Wagner AK, Chan KA, Dashevsky I, et al. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf Jun;15(6): Keks, Hope, Keogh et al. Switching and stopping antidepressants. Aust Prescr Jun; 39(3): Ripley, VC. Pharmacotherapy of Depression and Anxiety.

Consultant Pharmacist Approach to Major Depressive Disorder

Consultant Pharmacist Approach to Major Depressive Disorder Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO Objectives What is Depression? Discuss the epidemiology of depression

More information

Depression & Anxiety in Adolescents

Depression & Anxiety in Adolescents Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with

More information

Adult Depression - Clinical Practice Guideline

Adult Depression - Clinical Practice Guideline 1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

Some newer, investigational approaches to treating refractory major depression are being used.

Some newer, investigational approaches to treating refractory major depression are being used. CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular

More information

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder: Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now

More information

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant. 1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number

More information

Presentation is Being Recorded

Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity

Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity 2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment

More information

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Drugs for Emotional and Mood Disorders Chapter 16

Drugs for Emotional and Mood Disorders Chapter 16 Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize

More information

Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association

Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association Our clinical advisor adds updated advice on electroconvulsive therapy, transcranial magnetic

More information

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Psychiatry curbside: Answers to a primary care doctor s top mental health questions Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing

More information

Partners in Care Quick Reference Cards

Partners in Care Quick Reference Cards Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association

More information

Children s Hospital Of Wisconsin

Children s Hospital Of Wisconsin Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types

More information

Depression: Assessment and Treatment For Older Adults

Depression: Assessment and Treatment For Older Adults Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca

More information

Antidepressant Medication Therapy in Primary Care July 25, 2013

Antidepressant Medication Therapy in Primary Care July 25, 2013 New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental

More information

Depression & Suicide 7/11/2017 DISCLOSURES. DSM 5 Depressive Disorders. Objectives

Depression & Suicide 7/11/2017 DISCLOSURES. DSM 5 Depressive Disorders. Objectives DISCLOSURES Depression & Suicide July 19, 2017 GenaLynne C. Mooneyham, MD, MS Pediatrics/Psychiatry/Child & Adolescent Psychiatry No financial disclosures There may be discussion of off label medication

More information

DEPRESSION. Dr. Jonathan Haverkampf, M.D.

DEPRESSION. Dr. Jonathan Haverkampf, M.D. Dr., M.D. Depression is one of the most common medical conditions, which can interfere with a person s quality of life, relationships and ability to work significantly. Fortunately, there are a number

More information

Primary Care: Referring to Psychiatry

Primary Care: Referring to Psychiatry Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives

More information

Depression Workshop 26 January 2007

Depression Workshop 26 January 2007 Depression Workshop 26 January 2007 Leslie G Walker Professor of Cancer Rehabilitation Donald M Sharp Senior Lecturer in Behavioural Oncology Mary B Walker Senior Clinical and Research Nurse Specialist

More information

A Basic Approach to Mood and Anxiety Disorders in the Elderly

A Basic Approach to Mood and Anxiety Disorders in the Elderly A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict

More information

Depressive and Bipolar Disorders

Depressive and Bipolar Disorders Depressive and Bipolar Disorders Symptoms Associated with Depressive and Bipolar Disorders Characteristics of mood symptoms Affects a person s well being, school, work, or social functioning Continues

More information

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

Mental illness A Broad Overview. Dr H Pathmanandam March 2017 Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate

More information

Manual of Clinical Psychopharmacology

Manual of Clinical Psychopharmacology Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School

More information

Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University

Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure

More information

Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School

Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical

More information

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)

More information

AN OVERVIEW OF ANXIETY

AN OVERVIEW OF ANXIETY AN OVERVIEW OF ANXIETY Fear and anxiety are a normal part of life. Normal anxiety keeps us alert. Intervention is required when fear and anxiety becomes overwhelming intruding on a persons quality of life.

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.

More information

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

9/24/2012. Amer M Burhan, MBChB, FRCP(C) Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression

More information

Disclosure Information

Disclosure Information Disclosure Information I have no financial relationships to disclose. I will discuss the off label use of several depression and anxiety medications in pediatric population Pediatric Depression & Anxiety

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Depression. There are several forms of depression (depressive disorders). Major depressive disorder and dysthymic disorder are the most common.

Depression. There are several forms of depression (depressive disorders). Major depressive disorder and dysthymic disorder are the most common. Depression Depression is a state of low mood and aversion to activity that can affect a person's thoughts, behavior, feelings and sense of well-being. People with depressed mood can feel sad, anxious,

More information

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Antidepressants and Sedatives David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Depression A frequent problem, affecting up to 5% of the population Common presentations

More information

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed

More information

This initial discovery led to the creation of two classes of first generation antidepressants:

This initial discovery led to the creation of two classes of first generation antidepressants: Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out

More information

Depression in Late Life

Depression in Late Life Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression

More information

Anxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC

Anxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC Anxiety Disorders- OCD Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC Anxiety Disorders - Epidemiology Anxiety disorders are the most common class of mental disorders Estimated lifetime prevalence rates

More information

Psychiatry in Primary Care: What is the Role of Pharmacist?

Psychiatry in Primary Care: What is the Role of Pharmacist? Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure

More information

Your journal: how can it help you?

Your journal: how can it help you? Journal Your journal: how can it help you? By monitoring your mood along with other symptoms like sleep, you and your treatment team will be better able to follow the evolution of your symptoms and therefore

More information

Child & Adolescent Psychiatry (a brief overview)

Child & Adolescent Psychiatry (a brief overview) Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina

More information

Treatment-resistant depression in primary care

Treatment-resistant depression in primary care Treatment-resistant depression in primary care Interprofessional CME, October 2017 Brian J. Mickey, MD, PhD Associate Professor School of Medicine Department of Psychiatry Disclosures Speakers bureau:

More information

DISEASES AND DISORDERS

DISEASES AND DISORDERS DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related

More information

PSYCH 235 Introduction to Abnormal Psychology. Agenda/Overview. Mood Disorders. Chapter 11 Mood/Bipolar and Related disorders & Suicide

PSYCH 235 Introduction to Abnormal Psychology. Agenda/Overview. Mood Disorders. Chapter 11 Mood/Bipolar and Related disorders & Suicide PSYCH 235 Introduction to Abnormal Psychology Chapter 11 Mood/Bipolar and Related disorders & Suicide 1 Agenda/Overview Mood disorders Major depression Persistent Depressive Disorder (Dysthymia) Bipolar

More information

Mood Disorders for Care Coordinators

Mood Disorders for Care Coordinators Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders

More information

Depression in the Eldery Handout Package

Depression in the Eldery Handout Package Depression in the Eldery Handout Package Depression in the Elderly 1 Learning Objectives Upon completion of this module, you should be able to: 1. State the prevalence and describe the consequences of

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

TREATING MAJOR DEPRESSIVE DISORDER

TREATING MAJOR DEPRESSIVE DISORDER TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.

More information

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on

More information

ANTI-DEPRESSANT MEDICATIONS

ANTI-DEPRESSANT MEDICATIONS ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change

More information

Depression in Pregnancy

Depression in Pregnancy TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date

More information

Treating Childhood Depression in Pediatrics. Martha U. Barnard, Ph.D. University of Kansas Medical Center Pediatrics/Behavioral Sciences

Treating Childhood Depression in Pediatrics. Martha U. Barnard, Ph.D. University of Kansas Medical Center Pediatrics/Behavioral Sciences Treating Childhood Depression in Pediatrics Martha U. Barnard, Ph.D. University of Kansas Medical Center Pediatrics/Behavioral Sciences Objectives The learner will: Describe the signs and symptoms of childhood

More information

Depressive, Bipolar and Related Disorders

Depressive, Bipolar and Related Disorders Depressive, Bipolar and Related Disorders Robert Kelly, MD Assistant Professor of Psychiatry Weill Cornell Medical College White Plains, New York Lecture available at www.robertkelly.us Financial Conflicts

More information

Depression After Traumatic Brain Injury (TBI)

Depression After Traumatic Brain Injury (TBI) Depression After Traumatic Brain Injury (TBI) A resource for individuals with traumatic brain injury and their supporters This presentation is based on TBI Model Systems research and was developed with

More information

Handout 3: Mood Disorders

Handout 3: Mood Disorders Handout 3: Mood Disorders Mood disorders are called affective (emotional) disorders. There are two categories of mood disorders: Depressive Disorders Bipolar Affective Disorders Depressive Disorders Minor

More information

Depression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people

Depression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people Content Depression Dr. Anna Lam Associate Consultant Department of Psychiatry, Queen Mary Hospital Honorary Clinical Assistant Professor Li Ka Shing Faculty of Medicine, The University of Hong Kong 1.

More information

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology Contemporary Psychiatric-Mental Health Nursing Chapter 7 The Science of Psychopharmacology Psychopharmacology A primary treatment mode of psychiatric-mental health nursing care Psychopharmacology - continued

More information

DSM5: How to Understand It and How to Help

DSM5: How to Understand It and How to Help DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental

More information

Session outline. Introduction to depression Assessment of depression Management of depression Follow-up Review

Session outline. Introduction to depression Assessment of depression Management of depression Follow-up Review Depression 1 Session outline Introduction to depression Assessment of depression Management of depression Follow-up Review 2 Activity 1: Person s story followed by group discussion Present the first person

More information

Anxiety Disorders: First aid and when to refer on

Anxiety Disorders: First aid and when to refer on Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

Νευροφυσιολογία και Αισθήσεις

Νευροφυσιολογία και Αισθήσεις Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and

More information

Norpramin (desipramine)

Norpramin (desipramine) Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)

More information

Understanding Depression

Understanding Depression Understanding Depression What causes Depression? Family History Having family members who have depression may increase a person s risk Deficiencies of certain chemicals in the brain may lead to depression

More information

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Chan-Hyung Kim, MD Severance Mental Health Hospital Institute of Behavioral Science in Medicine Diagnostic Criteria Pyramid Etiologic Pathophysiologic

More information

Quick Guide to Common Antidepressants-Adults

Quick Guide to Common Antidepressants-Adults Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa

More information

Depression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital

Depression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Depression and RLS John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School A 42 year old man has a three

More information

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant

More information

DSM-5 Criteria: Major Depressive Disorder

DSM-5 Criteria: Major Depressive Disorder DSM-5 Criteria: Major Depressive Disorder Box 3. Major Depressive Episode: DSM-5 Diagnosis: Major Depressive Disorder Five (or more) of the following symptoms have been present during the same 2-week period

More information

Depression in Persons with Developmental Disabilities. Helene Silverblatt MD UNM-TEASC Team December 7, 2007

Depression in Persons with Developmental Disabilities. Helene Silverblatt MD UNM-TEASC Team December 7, 2007 Depression in Persons with Developmental Disabilities Helene Silverblatt MD UNM-TEASC Team December 7, 2007 The Bottom Line Indeed, the professional who is in the habit of gathering nonverbal communications

More information

Depression: Identification, Evaluation and Management in Primary Care

Depression: Identification, Evaluation and Management in Primary Care Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2010 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco

More information

DEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research

DEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research infoaging guides DISEASES OF AGING DEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research WHAT IS DEPRESSION AND WHY IS IT IMPORTANT? Depression is a mood

More information

Treatment of Depression in the Primary Care Office

Treatment of Depression in the Primary Care Office Treatment of Depression in the Primary Care Office Paul E.A. Glaser, MD, PhD Departments of Psychiatry, Pediatrics and Anatomy & Neurobiology University of Kentucky November 5, 2010 Disclosures of Potential

More information

ENTITLEMENT ELIGIBILITY GUIDELINE DEPRESSIVE DISORDERS

ENTITLEMENT ELIGIBILITY GUIDELINE DEPRESSIVE DISORDERS ENTITLEMENT ELIGIBILITY GUIDELINE DEPRESSIVE DISORDERS MPC 03000 ICD-9 296.2, 296.3, 300.4, 311 ICD-10 F32, F33, F34.1 DEFINITION Depressive Disorders is a category of conditions in the Diagnostic and

More information

How to treat depression with medication: Some rules of thumb

How to treat depression with medication: Some rules of thumb How to treat depression with medication: Some rules of thumb R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon. Consultant Psychiatrist Regional

More information

AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview

AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview February 7, 2012 Robert McCarron, D.O. Assosicate Clinical Professor Internal Medicine / Psychiatry / Pain Medicine UC Davis,

More information

Elavil (amitriptyline)

Elavil (amitriptyline) Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information

More information

Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health

Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health Solutions, PLLC www.bartoncbt.com Academic and Pop-Culture

More information

When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation

When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference Goals for presentation *To review DSM-V criteria for some of the most frequently

More information

The Role of the Family Physician in Managing Depression

The Role of the Family Physician in Managing Depression Middle East Journal of Family Medicine, 2004; Vol. 2 (2) The Role of the Family Physician in Managing Depression 1-Homoud F. Al-Zuabi, BSc.MBBCh.RCGP. Head of Ferdous Health Center Farwania Primary Health

More information

Seasonal Affective Disorder: Diagnostic Issues

Seasonal Affective Disorder: Diagnostic Issues CHAPTER 1 Seasonal Affective Disorder: Diagnostic Issues Definition and diagnostic criteria Prevalence and burden Screening Clinical features Differential diagnosis Variants of SAD Further reading 1 Definition

More information

Drugs, Society and Behavior

Drugs, Society and Behavior SOCI 270 Drugs, Society and Behavior Spring 2016 Professor Kurt Reymers, Ph.D. Chapter 8 Medication for Mental Disorders 1. Mental Disorders: a. The Medical Model Model: symptoms diagnosis determination

More information

Joel V. Oberstar, M.D. 1

Joel V. Oberstar, M.D. 1 Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical

More information

depression and anxiety in later life clinical challenges and creative research

depression and anxiety in later life clinical challenges and creative research 2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

MAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE

MAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE MAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE Reviewed and Updated by the Behvioral Health Subcommittee 7/20/2017 Topic Purpose Access Assessment 7/2017 Recommendations SummaCare Health Plan bases its Clinical

More information